Format

Send to

Choose Destination
Mayo Clin Proc. 1995 Jan;70(1):66-8.

Cavitary pulmonary infarct in immunocompromised hosts.

Author information

1
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Abstract

Pulmonary disease in immunocompromised patients is common, but cavitary lung disease is less common and is usually associated with a fungal or mycobacterial infection. Pulmonary embolism is a noninfectious cause of a cavitary pulmonary process. Pulmonary embolism causes infarction in fewer than 15% of cases, and only about 5% of infarctions cavitate. Herein we describe two cases of cavitary infarcts in immunocompromised patients and review the clinical aspects of pulmonary infarcts and cavitation. Cavitary pulmonary infarction has been reported only rarely in immunocompromised patients. It is a dangerous but treatable pulmonary disease that must be considered in the differential diagnosis of immuno-compromised patients with lung disease.

PMID:
7808055
DOI:
10.1016/S0025-6196(11)64668-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center